The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Inhibition of Angiotensin II-Induced Vascular Smooth Muscle Cell Hypertrophy by Different Catechins

  • Zheng, Ying (Department of Pharmacology, College of Medicine, Chungbuk National University) ;
  • Song, Hye-Jin (Department of Pharmacology, College of Medicine, Chungbuk National University) ;
  • Yun, Seok-Hee (Department of Pharmacology, College of Medicine, Chungbuk National University) ;
  • Chae, Yeon-Jeong (Department of Pharmacology, College of Medicine, Chungbuk National University) ;
  • Jia, Hao (Department of Pharmacology, College of Medicine, Chungbuk National University) ;
  • Kim, Chan-Hyung (Department of Pharmacology, College of Medicine, Chungbuk National University) ;
  • Ha, Tae-Sun (Department of Pediatrics, College of Medicine, Chungbuk National University) ;
  • Sachinidis, Agapios (Center of Physiology and Pathophysiology, University of Cologne) ;
  • Ahn, Hee-Yul (Department of Pharmacology, College of Medicine, Chungbuk National University) ;
  • Davidge, Sandra T. (Department of Obstetrics and Gynecology and Physiology, Perinatal Research Center, University of Alberta)
  • Published : 2005.04.21
Download PDF
⟨ Previous Next ⟩

Abstract

A cumulative evidence indicates that consumption of tea catechin, flavan-3-ol derived from green tea leaves, lowers the risk of cardiovascular diseases. However, a precise mechanism for this cardiovascular action has not yet been fully understood. In the present study, we investigated the effects of different green tea catechins, such as epigallocatechin-3 gallate (EGCG), epigallocatechin (EGC), epicatechin-3 gallate (ECG), and epicatechin (EC), on angiotensin II (Ang II)-induced hypertrophy in primary cultured rat aortic vascular smooth muscle cell (VSMC). [$^3H$]-leucine incorporation was used to assess VSMC hypertrophy, protein kinase assay, and western blot analysis were used to assess mitogen-activated protein kinase (MAPK) activity, and RT-PCR was used to assess c-jun or c-fos transcription. Ang II increased [$^3H$]-leucine incorporation into VSMC. However, EGCG and ECG, but not EGC or EC, inhibited [$^3H$]-leucine incorporation increased by Ang II. Ang II increased phosphorylation of c-Jun, extracellular-signal regulated kinase (ERK) 1/2 and p38 MAPK in VSMC, however, EGCG and ECG , but not EGC or EC, attenuated c-Jun phosphorylation increased by Ang II. ERK 1/2 and p38 MAPK phosphorylation induced by Ang II were not affected by any catechins. Ang II increased c-jun and c-fos mRNA expression in VSMC, however, EGCG inhibited c-jun but not c-fos mRNA expression induced by Ang II. ECG, EGC and EC did not affect c-jun or c-fos mRNA expression induced by Ang II. Our findings indicate that the galloyl group in the position 3 of the catechin structure of EGCG or ECG is essential for inhibiting VSMC hypertrophy induced by Ang II via the specific inhibition of JNK signaling pathway, which may explain the beneficial effects of green tea catechin on the pathogenesis of cardiovascular diseases observed in several epidemiological studies.

Keywords

References

  1. Ahn HY, Hadizadeh KR, Seul C, Yun YP, Vetter H, Sachinidis A. Epigallocatechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell 10: 1093-1104, 1999 https://doi.org/10.1091/mbc.10.4.1093
  2. Benelli R, Vene R, Bisacchi D, Garbisa S, Albini A. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem 383: 101-105, 2002 https://doi.org/10.1515/BC.2002.010
  3. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Circ Res 80: 607-616, 1997 https://doi.org/10.1161/01.RES.80.5.607
  4. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin IIstimulated protein synthesis in cultured smooth muscle cells. Hypertension 13: 305-314, 1989 https://doi.org/10.1161/01.HYP.13.4.305
  5. Black MJ, Adams MA, Bobik A, Campbell JH, Campbell GR. Vascular smooth muscle polyploidy in the development and regression of hypertension. Clin Exp Pharmacol Physiol 15: 345-348, 1988 https://doi.org/10.1111/j.1440-1681.1988.tb01085.x
  6. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T. Intracellular signaling of angiotensin II-induced P70 S6 kinase phosphorylation at Ser411 in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase and Akt. J Biol Chem 274: 36843-36851, 1999 https://doi.org/10.1074/jbc.274.52.36843
  7. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749-756, 1988 https://doi.org/10.1161/01.RES.62.4.749
  8. Giasson E, Meloche S. Role of P70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J Biol Chem 270: 5225-5231, 1995 https://doi.org/10.1074/jbc.270.10.5225
  9. Gille H, Sharrocks A, Shaw P. Phosphorylation of p62TCF by MAP kinases stimulates ternary complex formation at c-Fos promoter. Nature 358: 414-417, 1992 https://doi.org/10.1038/358414a0
  10. Hixon ML, Muro-Cacho C, Wagner MW, Obejero-Paz C, Mille E, Fujio Y, Kureishi Y, Hassold T. Walsh K, Gualberto A. Akt/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest 106: 1011-1020, 2000 https://doi.org/10.1172/JCI8252
  11. Hwang KC, Lee KH, Jang Y, Yun YP, Chung KH. Epigallocatechin-3-gallate inhibits basic fibroblast growth factor- induced intracellular signaling transduction pathway in rat aortic smooth muscle cells. J Cardiovasc Pharmacol 39: 271-277, 2002 https://doi.org/10.1097/00005344-200202000-00014
  12. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. Br Med J 310: 693-696, 1995 https://doi.org/10.1136/bmj.310.6981.693
  13. Kallunki T, Deng T, Hibi M, Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87: 929-939, 1996 https://doi.org/10.1016/S0092-8674(00)81999-6
  14. Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, Yoo HS, Yun YP. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovascular Pharmacol 38: 875-884, 2001 https://doi.org/10.1097/00005344-200112000-00009
  15. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995 https://doi.org/10.1074/jbc.270.28.16483
  16. McKay S, de Jongste JC, Saxena PR, Sharma HS. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol 18: 823-833, 1998 https://doi.org/10.1165/ajrcmb.18.6.2924
  17. Middleton Jr E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751, 2000
  18. Musti AM, Treier M, Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275: 400-402, 1997 https://doi.org/10.1126/science.275.5298.400
  19. Nagai K, Jiang MH, Hada J, Nagata T, Yajima Y, Yamamoto S, Nishizaki T. (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant. Brain Res 956: 319-322, 2002 https://doi.org/10.1016/S0006-8993(02)03564-3
  20. Nakagawa T, Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 40: 1745-1750, 2002 https://doi.org/10.1016/S0278-6915(02)00169-2
  21. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 51: 280-289, 1982 https://doi.org/10.1161/01.RES.51.3.280
  22. Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res 53: 491-501, 1983 https://doi.org/10.1161/01.RES.53.4.491
  23. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 67-674, 1991
  24. Rivera VM, Greenberg ME. Growth factor-induced gene expression: the ups and downs of c-fos regulation. New Biol 2: 751-758, 1990
  25. Sachinids A, Skach RA, Seul C, Ko Y, Hescheler J, Ahn HY, Fingerle J. Inhibition of the PDGF -receptor tyrosine phosohorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J 16: 893-895, 2002 https://doi.org/10.1096/fj.01-0799fje
  26. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322: 339-346, 1995 https://doi.org/10.1006/abbi.1995.1473
  27. Santana-Rios G, Orner GA, Amantana A, Provost C, Wu SY, Dashwood RH. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res 495: 61-74, 2001 https://doi.org/10.1016/S1383-5718(01)00200-5
  28. Servant MJ, Giasson E, Meloche S. Inhibition of growth factorinduced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem 271: 16047-16052, 1996 https://doi.org/10.1074/jbc.271.27.16047
  29. Smeal T, Hibi M, Kanin M. Altering the specificity of signal transduction cascades:positive regulation of c-Jun transcriptional activity by protein kinase A. EMBO 3: 6006-6010, 1994
  30. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A, Yokoyama M. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem 272: 16018-16022, 1997 https://doi.org/10.1074/jbc.272.25.16018
  31. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y, Yokoyama M. Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cell. Am J Physiol 276: H1927-H1934, 1999
  32. Takeuchi K, Nakamura N, Cook NS, Pratt RE, Dzau VJ. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem Biophys Res Commun 172: 1189-1194, 1990 https://doi.org/10.1016/0006-291X(90)91574-C
  33. Tijburg LB, Mattern T, Folts JD, Weisgerber UM, Katan MB. Tea flavonoids and cardiovascular diseases. Crit Rev Food Sci 37: 771-785, 1997 https://doi.org/10.1080/10408399709527802
  34. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998 https://doi.org/10.1074/jbc.273.24.15022
  35. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase by angiotensin II in vascular smooth muscle cells. J Bio Che 274: 22699-22704, 1999 https://doi.org/10.1074/jbc.274.32.22699
  36. Weber AA, Neuhaus T, Skach RA, Hescheler J, Ahn HY, Schror K, Ko Y, Sachinidis A. Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BBinduced cell signaling and mitogenesis. FASEB J 18: 128-130, 2004 https://doi.org/10.1096/fj.03-0007fje
  37. Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type I (HIV-1). Antiviral Res 53: 19-34, 2002 https://doi.org/10.1016/S0166-3542(01)00189-9
  38. Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H. Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55: 2081-2084, 1995
  39. Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T. Quercetin inhibits Shc- and phosphatidylinositol 3-kinasemediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 60: 656-665, 2001
  40. Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, Terao J, Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun 293: 1458-1465, 2002 https://doi.org/10.1016/S0006-291X(02)00407-2
  41. Zheng Y, Song HJ, Kim CH, Kim HS, Kim EG, Sachinidis A, Ahn HY. Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II. J Cardiovasc Pharmacol 43: 200-208, 2004 https://doi.org/10.1097/00005344-200402000-00006